Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition.

Frontera, Jennifer A; Guekht, Alla; Allegri, Ricardo F; Ashraf, Mariam; Baykan, Betül; Crivelli, Lucía; Easton, Ava; Garcia-Azorin, David; Helbok, Raimund; Joshi, Jatin; Koehn, Julia; Koralnik, Igor; Netravathi, M; Michael, Benedict; Nilo, Annacarmen; Özge, Aynur; Padda, Karanbir; Pellitteri, Gaia; Prasad, Kameshwar; Romozzi, Marina; Saylor, Deanna; Seed, Adam; Thakur, Kiran; Uluduz, Derya; Vogrig, Alberto; Welte, Tamara M; Westenberg, Erica; Zhuravlev, Dmitry; Zinchuk, Mikhail; Winkler, Andrea S     «

Frontera, Jennifer A; Guekht, Alla; Allegri, Ricardo F; Ashraf, Mariam; Baykan, Betül; Crivelli, Lucía; Easton, Ava; Garcia-Azorin, David; Helbok, Raimund; Joshi, Jatin; Koehn, Julia; Koralnik, Igor; Netravathi, M; Michael, Benedict; Nilo, Annacarmen; Özge, Aynur; Padda, Karanbir; Pellitteri, Gaia; Prasad, Kameshwar; Romozzi, Marina; Saylor, Deanna; Seed, Adam; Thakur, Kiran; Uluduz, Derya; Vogrig, Alberto; Welte, Tamara M; Westenberg, Erica; Zhuravlev, Dmitry; Zinchuk, Mikhail; Winkler, Andrea...     »

Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little data is available to guide treatment strategies for the most common symptoms. We conducted a scoping review of PubMed/Medline from 1/1/2020-4/1/2023 to identify studies addressing diagnosis and treatment of the most common post-acute neurological sequelae of COVID-19 including: cognitive impairment, sleep disorders, headache, dizziness/lightheadedness, fatigue, weakness, numbness/pain, anxiety, depression and post-traumatic stress disorder. Utilizing the available literature and international disease-specific society guidelines, we constructed symptom-based differential diagnoses, evaluation and management paradigms. This pragmatic, evidence-based consensus document may serve as a guide for a holistic approach to post-COVID neurological care and will complement future clinical trials by outlining best practices in the evaluation and treatment of post-acute neurological signs/symptoms.      «

Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little data is available to guide treatment strategies for the most common symptoms. We conducted a scoping review of PubMed/Medline from 1/1/2020-4/1/2023 to identify studies addressing diagnosis and treatment of the most common post-acute neurological sequelae of COVID-19 including: cognitive impairment, sleep disorders, headache, dizziness/lightheadedness, fatigue, weakness, numbness/pain, anxiety, depressio...     »